UNITED NATURAL PRODUCT ALLIANCE

  • About
    • UNPA Members >
      • Executive Members
      • Science & Technology Services Members
      • Associate Members
      • Featured Member Profiles
    • MOU Partners
    • UNPA Staff >
      • National Staff
      • Political Advisors
    • Policies & Endorsements
    • Education and Training
    • Photo Galleries >
      • Members' Retreat 2019
      • China Delegation 2018
      • UNPA 2019 Staff Retreat
    • UNPA Headquarters
    • Testimonials
  • News
    • UNPA News
    • UNPA In the News
    • Media Releases
    • Member/MOU Partner News
    • Employment Opportunities
  • Member Resources
    • Regulatory Resources >
      • GMPs >
        • Regulatory Dietary Supplements
      • FSMA >
        • PCQI
        • FSVP
      • Organics
      • Labeling/Claims >
        • Nutrition Facts label
      • Guidelines/Best Practices >
        • Monographs
      • Links and Resources
      • Global >
        • Canada
    • Member Memos
    • UNPA Digest
    • UNPA Forums
    • UNPA Presentations
    • Expert Insights Webinars
    • Education Archive
    • Exclusive Member Offers
    • Member Logos
  • Events
    • 2021 Training Schedule >
      • PCQI Training
      • GMP Inspection Training
      • FSVP Training
      • Intentional Audulteration (IA)
    • 2020 DSRS Speakers
    • Industry Calendar of Events
  • Join
  • Media
  • For Consumers
    • About Dietary Supplements
    • Dietary Supplement Caucus
    • Dietary Supplement Caucus Members
    • Additional Resources >
      • Botanical Adulteration Prevention Program
      • Integrative Medicine
      • Industry Associations
      • Terms & Acronyms
  • Contact
  • About
    • UNPA Members >
      • Executive Members
      • Science & Technology Services Members
      • Associate Members
      • Featured Member Profiles
    • MOU Partners
    • UNPA Staff >
      • National Staff
      • Political Advisors
    • Policies & Endorsements
    • Education and Training
    • Photo Galleries >
      • Members' Retreat 2019
      • China Delegation 2018
      • UNPA 2019 Staff Retreat
    • UNPA Headquarters
    • Testimonials
  • News
    • UNPA News
    • UNPA In the News
    • Media Releases
    • Member/MOU Partner News
    • Employment Opportunities
  • Member Resources
    • Regulatory Resources >
      • GMPs >
        • Regulatory Dietary Supplements
      • FSMA >
        • PCQI
        • FSVP
      • Organics
      • Labeling/Claims >
        • Nutrition Facts label
      • Guidelines/Best Practices >
        • Monographs
      • Links and Resources
      • Global >
        • Canada
    • Member Memos
    • UNPA Digest
    • UNPA Forums
    • UNPA Presentations
    • Expert Insights Webinars
    • Education Archive
    • Exclusive Member Offers
    • Member Logos
  • Events
    • 2021 Training Schedule >
      • PCQI Training
      • GMP Inspection Training
      • FSVP Training
      • Intentional Audulteration (IA)
    • 2020 DSRS Speakers
    • Industry Calendar of Events
  • Join
  • Media
  • For Consumers
    • About Dietary Supplements
    • Dietary Supplement Caucus
    • Dietary Supplement Caucus Members
    • Additional Resources >
      • Botanical Adulteration Prevention Program
      • Integrative Medicine
      • Industry Associations
      • Terms & Acronyms
  • Contact

Expert Insights ondemand

Will you need an IND to do dietary supplement research?

2/25/2014

 
Presented February 25, 2014 by Jay Udani, M.D.
Download a PDF of the PPT file for this presentation.

​On Jan. 21, the Food and Drug Administration (FDA) reopened a comment period for a controversial guidance that would require an Investigational New Drug (IND) application for clinical research studies of foods and dietary supplements. Currently, an IND is required for drug research, but not for foods and supplement product research.
INDs are utilized for drug research by FDA to determine if the product is “reasonably safe for initial use in humans, and if the compound exhibits pharmacological activity that justifies commercial development.”

If this guidance were to become law as written, among other things, it would have a chilling effect on innovation and product development, unnecessarily burden research institutions, and create an entirely new set of regulations for industry that are contrary to the current regulatory definitions and intentions for foods and supplements.

In this timely educational session, learn what you need to know about INDs:

  1. An understanding of the scope and key components of INDs
  2. Whenthey are appropriate for use in dietary supplement and food research
  3. The costs and timelines involved
  4. Areas of concern of this critical FDA guidance
Dr. Jay Udani, CEO and medical director of Medicus Research, will address these issues as he analyzes FDA’s guidance and explains how to navigate through this hot topic of confusion and concern.

Additionally, UNPA President Loren Israelsen will address UNPA’s position on the guidance and its plans to formally respond to FDA during the reopened comment period.

Comments are closed.
 © 2021 United Natural Products Alliance. All Rights Reserved.
Headquarters: 716 Fourth Avenue Salt Lake City, UT 84103
Mailing Address: 
6503 S Datura Street Littleton, CO 80120
801.474.2572 | info@unpa.com | homepage